Boston Scientific Plunges to $45.99 Annual Low After Analyst Target Cuts
BSX•Boston Scientific shares tumbled to $45.99, their lowest level this year, after multiple analysts slashed price targets, driving a 0.55% drop at Friday's close. The cuts underscore growing concerns over the company's future growth prospects among institutional analysts.
1. Stock Performance Decline
Boston Scientific shares fell to $45.99 last week, marking an annual low after a 0.55% decline at Friday’s close. This drop represents the weakest intraday trading level for the stock since the start of the year.
2. Analyst Price Target Cuts
Several analysts lowered their price targets on Boston Scientific, citing concerns over the firm's growth outlook and upcoming product pipeline milestones. These downgrades pressured investor sentiment and contributed directly to the recent share price slide.
